ALX Oncology Holdings Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -19.55 | -100% |
| P/S |
|
4.4 | 33.76 | -86.97% |
|
|
| P/BV |
|
3.42 | 4.82 | -29.07% |
|
|
| P/FCF |
|
-1.47 | 60.98 | -102.41% |
|
|
| Ev/Ebitda |
|
-3.8 | -22.12 | -82.83% |
|
|
| Ev/S |
|
1221.02 | 22.56 | 5311.54% |
|
|
| Ev/FCF |
|
-4.89 | 68.75 | -107.11% |
|
|
| E/P |
|
-0.8297 | 0.0178 | -4768.14% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.83 | -100% | -952.12 | -100% |
| ROE |
|
-84.76 | 9.61 | -982.38% |
|
|
| ROA |
|
-66.3 | 0.3359 | -19836.76% |
|
|
| ROIC |
|
-24.58 | 7.63 | -421.97% |
|
|
| ROS |
|
-30513.28 | -25.17 | 121128.21% |
|
|
| ROCE |
|
-89.76 | 15.33 | -685.45% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0662 | -3.67 | -98.19% | -0.1025 | -35.41% |
| Nеt Debt/Ebitda |
|
0.0307 | -3.44 | -100.89% |
|
|
| Debt/Ratio |
|
0.0462 | 0.1972 | -76.55% |
|
|
| Debt/Equity |
|
2.88 | 1.65 | 74.64% |
|
|
| Debt/Net Income |
|
-0.0697 | 10.31 | -100.68% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-42.86 | -56.89 | -24.66% |
| Growth impulse Ebitda 5 years |
|
801.29 | -64.81 | -1336.37% |
| Growth impulse Net Income 5 years |
|
737.53 | -58.33 | -1364.41% |
| Growth impulse FCF 5 years |
|
801.63 | -47 | -1805.6% |
| Growth impulse EPS 5 years |
|
326.73 | -32.41 | -1108.11% |
IP Score
4.15/10
